Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 350

    1.

    The effect of travoprost on daytime intraocular pressure in normal tension glaucoma: a randomised controlled trial.

    Ang GS, Kersey JP, Shepstone L, Broadway DC.

    Br J Ophthalmol. 2008 Aug;92(8):1129-33. Epub 2008 May 29.PMID: 18511540 [PubMed - indexed for MEDLINE]Related articles

    2.

    Long term effect of latanoprost on intraocular pressure in normal tension glaucoma.

    Ang A, Reddy MA, Shepstone L, Broadway DC.

    Br J Ophthalmol. 2004 May;88(5):630-4.PMID: 15090413 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Effect of travoprost on intraocular pressure during 12 months of treatment for normal-tension glaucoma.

    Suh MH, Park KH, Kim DM.

    Jpn J Ophthalmol. 2009 Jan;53(1):18-23. Epub 2009 Jan 30.PMID: 19184304 [PubMed - indexed for MEDLINE]Related articles

    5.

    Use of a Bayesian network to predict the nighttime intraocular pressure peak from daytime measurements.

    Nordmann JP, Berdeaux G.

    Clin Ther. 2007 Aug;29(8):1751-60; discussion 1750.PMID: 17919556 [PubMed - indexed for MEDLINE]Related articles

    6.

    Intraocular pressure lowering efficacy of travoprost.

    Przydryga JT, Egloff C; Swiss Start Study Group.

    Eur J Ophthalmol. 2004 Sep-Oct;14(5):416-22.PMID: 15506604 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of travoprost on aqueous humor dynamics in patients with elevated intraocular pressure.

    Toris CB, Zhan G, Fan S, Dickerson JE, Landry TA, Bergamini MV, Camras CB.

    J Glaucoma. 2007 Mar;16(2):189-95.PMID: 17473728 [PubMed - indexed for MEDLINE]Related articles

    8.

    Assessment of the cost effectiveness of travoprost versus latanoprost as single agents for treatment of glaucoma in France.

    Payet S, Denis P, Berdeaux G, Launois R.

    Clin Drug Investig. 2008;28(3):183-98.PMID: 18266403 [PubMed - indexed for MEDLINE]Related articles

    9.

    Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%.

    Feldman RM, Tanna AP, Gross RL, Chuang AZ, Baker L, Reynolds A, Prager TC; Additivity Study Group.

    Ophthalmology. 2007 Jul;114(7):1248-54. Epub 2007 May 23.PMID: 17509688 [PubMed - indexed for MEDLINE]Related articles

    10.

    A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.

    Maul E, Carrasco FG, Costa VP, Casiraghi JF, Vargas E, Sarmina JS, Mayol R.

    Clin Ther. 2007 Sep;29(9):1915-23.PMID: 18035191 [PubMed - indexed for MEDLINE]Related articles

    11.

    Circadian IOP-lowering efficacy of travoprost 0.004% ophthalmic solution compared to latanoprost 0.005%.

    García-Feijoo J, Martínez-de-la-Casa JM, Castillo A, Méndez C, Fernández-Vidal A, García-Sánchez J.

    Curr Med Res Opin. 2006 Sep;22(9):1689-97.PMID: 16968572 [PubMed - indexed for MEDLINE]Related articles

    12.

    Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma.

    Holló G, Kóthy P.

    Curr Med Res Opin. 2008 Jun;24(6):1755-61. Epub 2008 May 13.PMID: 18479590 [PubMed - indexed for MEDLINE]Related articles

    13.

    Comparing bimatoprost and travoprost in black Americans.

    Noecker RJ, Earl ML, Mundorf TK, Silverstein SM, Phillips MP.

    Curr Med Res Opin. 2006 Nov;22(11):2175-80.PMID: 17076978 [PubMed - indexed for MEDLINE]Related articles

    15.

    Comparison of diurnal intraocular pressure control by latanoprost versus travoprost : results of an observational survey.

    Denis P, Launois R, Devaux M, Berdeaux G.

    Clin Drug Investig. 2006;26(12):703-14.PMID: 17274677 [PubMed - indexed for MEDLINE]Related articles

    16.

    [The Slovak study of the travoprost treatment efficacy]

    Potocký M.

    Cesk Slov Oftalmol. 2006 Jul;62(4):263-9. Slovak. PMID: 16895059 [PubMed - indexed for MEDLINE]Related articles

    17.

    Sustained effect of travoprost on diurnal and nocturnal intraocular pressure.

    Sit AJ, Weinreb RN, Crowston JG, Kripke DF, Liu JH.

    Am J Ophthalmol. 2006 Jun;141(6):1131-3.PMID: 16765686 [PubMed - indexed for MEDLINE]Related articles

    18.

    The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.

    Yildirim N, Sahin A, Gultekin S.

    J Glaucoma. 2008 Jan-Feb;17(1):36-9.PMID: 18303382 [PubMed - indexed for MEDLINE]Related articles

    19.

    Evaluation of the role of travoprost 0.004% ophthalmic solution in the management of open angle glaucoma and ocular hypertensive patients.

    Chiselită D; Pentru Eastern European Start Study Group.

    Oftalmologia. 2007;51(2):81-6.PMID: 17937041 [PubMed - indexed for MEDLINE]Related articles

    20.

    Efficacy and safety of latanoprost versus travoprost in exfoliative glaucoma patients.

    Konstas AG, Kozobolis VP, Katsimpris IE, Boboridis K, Koukoula S, Jenkins JN, Stewart WC.

    Ophthalmology. 2007 Apr;114(4):653-7. Epub 2006 Dec 29.PMID: 17197028 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data